Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidotimod oral solution in recurrent respiratory tract infections in children
CTR20191766Phase 4Completed
- Sponsor
- Hainan Puli Pharmaceutical
- Start
- Nov 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of pidotimod in Airways Infection, sponsored by Hainan Puli Pharmaceutical. Started Nov 2019; status: completed.
02
Drugs
pidotimod
03
Conditions
Airways Infection
Beyond the preview
Go deeper on CTR20191766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191766.